Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis

D M Gujral1, M Long2, J W G Roe3

  • 1Head and Neck Unit, The Royal Marsden Hospital, London, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|November 6, 2016
PubMed
Summary

Carotid-sparing intensity-modulated radiotherapy (IMRT) for early glottis cancer shows promise but lacks consensus on target volumes and dose constraints. Further research is needed to establish its long-term benefits and standardize protocols.

Related Concept Videos